Doximity, Inc. (NASDAQ:DOCS) Holdings Cut by Cwm LLC

Cwm LLC cut its stake in shares of Doximity, Inc. (NASDAQ:DOCSFree Report) by 24.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,782 shares of the company’s stock after selling 1,240 shares during the quarter. Cwm LLC’s holdings in Doximity were worth $165,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Oak Thistle LLC acquired a new position in Doximity during the 1st quarter valued at approximately $323,000. Allspring Global Investments Holdings LLC acquired a new position in shares of Doximity during the first quarter valued at $583,000. State of Michigan Retirement System grew its position in shares of Doximity by 6.0% during the first quarter. State of Michigan Retirement System now owns 30,000 shares of the company’s stock worth $807,000 after acquiring an additional 1,700 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. bought a new position in shares of Doximity during the first quarter worth about $416,000. Finally, Principal Financial Group Inc. increased its holdings in shares of Doximity by 5.5% in the 1st quarter. Principal Financial Group Inc. now owns 460,444 shares of the company’s stock worth $12,391,000 after acquiring an additional 23,993 shares during the period. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Canaccord Genuity Group upped their target price on shares of Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Barclays raised Doximity from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $35.00 to $52.00 in a report on Tuesday, October 15th. Wells Fargo & Company cut Doximity from an “equal weight” rating to an “underweight” rating and lowered their target price for the company from $27.00 to $19.00 in a research report on Thursday, July 18th. Bank of America boosted their price target on Doximity from $32.00 to $45.00 and gave the stock a “neutral” rating in a research report on Monday, October 7th. Finally, Truist Financial reissued a “hold” rating and set a $35.00 price target (up from $31.00) on shares of Doximity in a report on Wednesday, August 14th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Doximity presently has a consensus rating of “Hold” and a consensus price target of $35.83.

View Our Latest Research Report on Doximity

Insider Activity

In related news, Director Watkin Phoebe L. Yang sold 1,011 shares of Doximity stock in a transaction on Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the transaction, the director now directly owns 11,258 shares in the company, valued at $287,529.32. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In related news, CFO Anna Bryson sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $35.00, for a total value of $1,050,000.00. Following the completion of the sale, the chief financial officer now owns 309,627 shares in the company, valued at approximately $10,836,945. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Watkin Phoebe L. Yang sold 1,011 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $25.54, for a total transaction of $25,820.94. Following the completion of the transaction, the director now directly owns 11,258 shares of the company’s stock, valued at $287,529.32. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 35,451 shares of company stock worth $1,201,018. Insiders own 39.40% of the company’s stock.

Doximity Trading Down 1.8 %

Shares of Doximity stock opened at $41.41 on Thursday. Doximity, Inc. has a 52 week low of $19.89 and a 52 week high of $44.88. The stock has a market cap of $7.68 billion, a PE ratio of 57.51, a price-to-earnings-growth ratio of 5.29 and a beta of 1.29. The company’s 50-day moving average price is $39.75 and its two-hundred day moving average price is $31.53.

Doximity (NASDAQ:DOCSGet Free Report) last released its earnings results on Thursday, August 8th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.06. The business had revenue of $126.68 million for the quarter, compared to the consensus estimate of $119.88 million. Doximity had a net margin of 32.53% and a return on equity of 19.26%. On average, equities analysts predict that Doximity, Inc. will post 0.8 EPS for the current fiscal year.

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Read More

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.